生物技术进展 ›› 2026, Vol. 16 ›› Issue (2): 327-337.DOI: 10.19586/j.2095-2341.2025.0189

• 进展评述 • 上一篇    

终末期肾病中细胞焦亡与铁死亡的机制及营养干预研究进展

杨茜1(), 秦伟2()   

  1. 1.武警四川总队医院肾内科,四川 乐山 614000
    2.四川大学华西医院肾内科,成都 610041
  • 收稿日期:2025-12-24 接受日期:2026-01-29 出版日期:2026-03-25 发布日期:2026-04-27
  • 通讯作者: 秦伟
  • 作者简介:杨茜E-mail: coffeeyanyang@sohu.com
  • 基金资助:
    四川省科技计划重点研发项目(2022YFS0150)

Advances on Mechanisms of Pyroptosis and Ferroptosis in End-stage Renal Disease and Nutritional Interventions

Qian YANG1(), Wei QIN2()   

  1. 1.Department of Nephrology,Sichuan Provincial Armed Police Corps Hospital,Sichuan Leshan 614000,China
    2.Department of Nephrology,West China Hospital of Sichuan University,Chengdu 610041,China
  • Received:2025-12-24 Accepted:2026-01-29 Online:2026-03-25 Published:2026-04-27
  • Contact: Wei QIN

摘要:

慢性终末期肾病(end-stage renal disease, ESRD)作为现代肾脏病学面临的重大挑战,其病程进展与程序性细胞死亡(programmed cell death, PCD)密切相关,尤其是细胞焦亡和铁死亡发挥核心调控作用。这些PCD过程不仅受遗传和病理信号调控,还显著依赖机体营养状态与代谢供能水平。尽管围绕“营养-PCD-ESRD”的关联研究日益增多,但相关证据分散且机制认识尚未统一。基于此,系统回顾了ESRD及维持性血液透析(maintenance hemodialysis, MHD)患者中细胞焦亡与铁死亡的分子机制,明确了细胞焦亡通过“启动-放大-扩展”3阶段通路、铁死亡经“铁超载-抗氧化失衡-脂质过氧化放大”核心轴线,共同推动肾脏不可逆损伤。重点梳理了锌、维生素D、ω-3多不饱和脂肪酸、硒、维生素E、左卡尼汀及膳食纤维等营养素,通过调控上述PCD关键节点发挥的干预效应,证实营养干预可通过抑制炎性小体激活、修复抗氧化防御、调节铁代谢等多途径延缓疾病进展。同时指出当前精准营养治疗面临患者异质性高、证据强度不足、单一干预局限等挑战,提出未来需建立PCD 特征导向的精准分型体系、发展多靶点协同干预策略及配套技术支撑的研究方向以期为ESRD/MHD 患者的营养干预提供机制依据与转化思路,为基础研究与临床策略提供了参考。

关键词: 终末期肾病, 程序性细胞死亡, 细胞焦亡, 铁死亡, 尿毒症微环境, 疾病修饰性营养策略

Abstract:

Chronic end-stage renal disease (ESRD) represents a major challenge in modern nephrology. Its progression is closely associated with programmed cell death (PCD), among which pyroptosis and ferroptosis play core regulatory roles. These PCD processes are regulated not only by genetic and pathological signals but also significantly dependent on nutritional status and metabolic energy supply. Although studies on the “nutrition-PCD-ESRD” axis have been increasing, relevant evidence remains fragmented and mechanistic understanding has not been unified. Accordingly, this review systematically summarized the molecular mechanisms of pyroptosis and ferroptosis in patients with ESRD and maintenance hemodialysis (MHD). Pyroptosis contributes to irreversible kidney injury through a three-stage pathway: initiation, amplification, and propagation. Ferroptosis is driven by the core axis of iron overload, antioxidant imbalance, and lipid peroxidation amplification. Both pathways are key drivers of irreversible renal damage. This review further focused on the intervention effects of nutrients including zinc, vitamin D, ω-3 polyunsaturated fatty acids, selenium, vitamin E, L-carnitine, and dietary fiber by targeting key nodes of the above PCD pathways. It confirmed that nutritional interventions can delay disease progression through multiple pathways, such as inhibiting inflammasome activation, restoring antioxidant defense, and regulating iron metabolism. Meanwhile, current challenges in precision nutritional therapy were identified, including high patient heterogeneity, insufficient evidence strength, and limitations of single interventions. Future research directions were proposed, such as establishing a PCD-signature-based precise stratification system, developing multi-target synergistic intervention strategies, and strengthening supporting technologies. This review provided mechanistic evidence and translational ideas for nutritional intervention in ESRD/MHD patients, and offered a reference for basic research and clinical strategies.

Key words: ESRD, PCD, pyroptosis, ferroptosis, uremic microenvironment, disease-modifying nutritional strategies

中图分类号: